Perinatal Pharmacokinetics

Physiologically Based Pharmacokinetic Modeling: Science and Applications

Volumn , Issue , 2005, Pages 251-252

  Lee, Sun K ^a,b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

Children; Drugs; Fetuses; Growth; Lactational transfer; Methadone; Neonates; PBPK modeling of solvents; Perchloroethylene; Perinatal pharmacokinetics; Pregnant mother dam; Theophylline; Trichloroethylene

Indexed keywords

EID: 84890644586     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471478768.ch12     Document Type: Chapter

References (59)

1. Byczkowski, J. Z., and Fisher, J. W. (1994). Lactational transfer of tetrachloroethylene in rats. Risk Anal. 14, 339-349.
2. Byczkowski, J. Z., and Fisher, J. W. (1995). A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants. Comput. Methods Programs Biomed. 46, 155-163.
3. Byczkowski, J. Z., Kinkead, E. R., Leahy, H. F., Randall, G. M., and Fisher, J. W. (1994). Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model. Toxicol. Appl. Pharmacol. 125, 228-236.
4. Byczkowski, J. Z., and Lipscomb, J. C. (2001). Physiologically based pharmacokinetic modeling of the lactational transfer of methylmercury. Risk Anal. 21, 869-882.
5. Case, R. M., and Waterhouse, J. M. (1994). Human Physiology, Age, Stress, and the Environment. Oxford University Press, New York, 286 pp.
6. Clarke, D. O., Elswick, B. A., Welsch, F., and Conolly, R. B. (1993). Pharmacokinetics of 2- methoxyethanol and 2-methoxyacetic acid in the pregnant mouse, a physiologically based mathematical model. Toxicol. Appl. Pharmacol. 121, 239-252.
7. Clewell, H. J, 3rd, Andersen, M. E., Wills, R. J., and Latriano, L. (1997). A physiologically based pharmacokinetic model for retinoic acid and its metabolites. J. Am. Acad. Dermatol. 36(3 Pt 2), S77-S85.
8. Clewell, H. J., Gearhart, J. M., Gentry, P. R., Covington, T. R., VanLandingham, C. B., Crump, K. S., and Shipp, A. M. (1999). Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal. 19, 547-558.
9. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Covington, T. R., Banton, M. I., and Andersen, M. E. (2001). Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol. Sci. 63, 160-172.
10. Clewell, H. J., Gentry, P. R., Covington, T. R., Sarangapani, R., and Teeguarden, J. G. (2004). Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 79, 381-393.
11. Clewell, R. A., and Gearhart, J. M. (2002). Pharmacokinetics of toxic chemicals in breast milk: Use of PBPK models to predict infant exposure. Environ. Health Perspect. 110, A333-A337.
12. Clewell, R. A., Merrill, E. A., and Robinson, P. J. (2001). The use of physiologically based models to integrate diverse data sets and reduce uncertainty in the prediction of perchlorate and iodide kinetics across life stages and species. Toxicol. Ind. Health 17, 210-222.
13. Clewell, R. A., Merrill, E. A., Yu, K. O., Mahle, D. A., Sterner, T. R., Fisher, J. W., Gearhart, J. M. (2003a). Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling. Toxicol. Sci. 74, 416-436.
14. Clewell, R. A., Merrill, E. A., Yu, K. O., Mahle, D. A., Sterner, T. R., Mattie, D. R., Robinson, P. J., Fisher, J. W., and Gearhart, J. M. (2003b). Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: A physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. Toxicol. Sci. 73, 235-255.
15. Corley, R. A., Mast, T. J., Carney, E. W., Rogers, J. M., and Daston, G. P. (2003). Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessment. CRC Crit. Rev. Toxicol. 33, 137-211.
16. Davis, J. A., and Dobbing, J. (1981). Scientific Foundations of Pediatrics. Heinemann, London.
17. Fisher, D. A. (1992). Endocrinology of Fetal Development. Saunders, Philadelphia.
18. Fisher, J., Mahle, D., Bankston, L., Greene, R., and Gearhart, J. (1997). Lactational transfer of volatile chemicals in breast milk. Am. Ind. Hyg. Assoc. J. 58, 425-431.
19. Fisher, J. W., Whittaker, T. A., Taylor, D. H., Clewell, H. J., III, and Andersen, M. E. (1989). Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 99, 395- 414.
20. Fisher, J. W., Whittaker, T. A., Taylor, D. H., Clewell, H. J., III, and Andersen, M. E. (1990). Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 102, 497-513.
21. Gabrielsson, J. L., and Groth, T. (1988). An extended physiological pharmacokinetic model of methadone disposition in the rat: validation and sensitivity analysis. J. Pharmacokinet. Biopharm. 16, 183- 201.
22. Gabrielsson, J. L., and Paalzow, L. K. (1983). A physiological pharmacokinetic model for morphine disposition in the pregnant rat. J. Pharmacokinet. Biopharm. 11, 147-163.
23. Gabrielsson, J. L., Paalzow, L. K., and Nordstrom, L. (1984). A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat. J. Pharmacokinet. Biopharm. 12, 149-165.
24. Gabrielsson, J. L., Johansson, P., Bondesson, U., and Paalzow, L. K. (1985). Analysis of methadone disposition in the pregnant rat by means of a physiological flow model. J. Pharmacokinet. Biopharm. 13, 355-372.
25. Gabrielsson, J. L., Johansson, P., Bondesson, U., Karlsson, M., and Paalzow, L. K. (1986). Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model. J. Pharmacokinet. Biopharm. 14, 381-395.
26. Gargas, M. L., Tyler, T. R., Sweeney, L. M., Corley, R. A., Weitz, K. K., Mast, T. J., Paustenbach, D. J., and Hays, S. M. (2000a). A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human. Toxicol. Appl. Pharmacol. 165, 53-62.
27. Gargas, M. L., Tyler, T. R., Sweeney, L. M., Corley, R. A., Weitz, K. K., Mast, T. J., Paustenbach, D. J., and Hays, S. M. (2000b). A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human. Toxicol. Appl. Pharmacol. 165, 63-73.
28. Gearhart, J. M., Clewell, H. J., Crump, K. S., Shipp, A. M., and Silvers, A. (1995). Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in a large epidemiologic study. Water Air and Soil Pollution 80, 49-58.
29. Gentry, P. R., Covington, T. R., Andersen, M. E., and Clewell, H. J. (2002). Application of a physiologically-based pharmacokinetic model for isopropanol in the derivation of an RfD/RfC. Reg. Toxicol. Pharmacol. 36, 51-68.
30. Gentry, P. R., Covington, T. R. Andersen, M. E., and Clewell, H. J. (2003a). Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J. Toxicol. Environ. Health Pt. A 66, 2209-2225.
31. Gentry, P. R., Covington, T. R., and Clewell, H. J. (2003b). Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Reg. Toxicol. Pharmacol. 38, 1-16.
32. Ginsberg, G., Hattis, D., and Sonawane, B. (2004). Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicol. Appl. Pharmacol. 198, 164-183.
33. Goehbloed, J. F. (1976). The embryonic and postnatal growth of rat and mouse. Acta Anat. 95, 8-33.
34. Gray, D. G. (1995). A physiologically based pharmacokinetic model for methyl mercury in the pregnant rat and fetus. Toxicol. Appl. Pharmacol. 132, 91-102.
35. Hays, S. M., Elswick, B. A., Blumenthal, G. M., Welsch, F., Conolly, R. B., and Gargas, M. L. (2000). Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2- methoxyacetic acid disposition in pregnant rats. Toxicol. Appl. Pharmacol. 163, 67-74.
36. Huggett, A. S., and Widdas, W. F. (1951). The relationship between mammalian foetal weight and conception age. J. Physiol. 114, 306-317.
37. Kawahara, M., Nanbo, T., and Tsuji, A. (1998). Physiologically based pharmacokinetic prediction of pphenylbenzoic acid disposition in the pregnant rat. Biopharm. Drug Dispos. 19, 445-453.
38. Kim, C. S., Binienda, Z., and Sandberg, J. A. (1996). Construction of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in the developing rabbit brain. Toxicol. Appl. Pharmacol. 136, 250-259.
39. Linzell, J. L., Peaker, M., and Taylor, J. C. (1975). The effects of prolactin and oxytocin on milk secretion and on the permeability of the mammary epithelium in the rabbit. J. Physiol. 253, 547-563.
40. Luecke, R. H., Wosilait, W. D., Pearce, B. A., and Young, J. F. (1994). A physiologically based pharmacokinetic computer model for human pregnancy. Teratology 49, 90-103.
41. Merrill, E. A., Clewell, R. A., Gearhart, J. M., Robinson, P. J., Sterner, T. R., Yu, K. O., Mattie, D. R., Fisher, J. W. (2003). PBPK predictions of perchlorate distribution and its effect on thyroid uptake of radioiodide in the male rat. Toxicol Sci. 73, 256-269.
42. National Research Council. (1993). Pesticides in the Diets of Infants and Children. National Academy Press, Washington, D.C., 386 pp.
43. O'Flaherty, E. J., Scott, W., Schreiner, C., and Beliles, R. P. (1992). Aphysiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid. Toxicol. Appl. Pharmacol. 112, 245-256.
44. O'Flaherty, E. J., Nau, H., McCandless, D., Beliles, R. P., Schreiner, C. M., and Scott, W. J. Jr. (1995). Physiologically based pharmacokinetics of methoxyacetic acid: Dose-effect considerations in C57BL/6 mice. Teratology 52, 78-89.
45. Olanoff, L. S., and Anderson, J. M. (1980). Controlled release of tetracycline-III: A physiological pharmacokinetic model of the pregnant rat. J. Pharmacokinet. Biopharm. 8, 599-620.
46. Oskarsson, A., Palminger Hallen, I., Sundberg, J., and Petersson Grawe, K. (1998). Risk assessment in relation to neonatal metal exposure. Analyst 123, 19-23.
47. Rice, D., and Barone, S., Jr. (2000). Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ. Health Perspect. 108(Suppl 3), 511-533.
48. Rudolf, A. M. (1992). Pediatrics, Saunders, Philadelphia.
49. Sarangapani, R., Gentry, P. R., Covington, T. R., Teeguarden, J. G., and Clewell, H. J. (2003). Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 15, 987-1016.
50. Schreiber, J. S. (1993). Predicted infant exposure to tetrachloroethene in human breastmilk. Risk Anal. 13, 515-524.
51. Shelley, M. L., Andersen, M. E., and Fisher, J. W. (1988). An inhalation distribution model for the lactating mother and nursing child. Toxicol. Lett. 43, 23-29.
52. Spitzer, A., and Chevalier, R. L. (1992). The Developing Kidney and the Process of Kidney. Raven, New York.
53. Terry, K. K., Elswick, B. A., Welsh, F., and Conolly, R. B. (1995). Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse. Toxicol. Appl. Pharmacol. 132, 103-114.
54. US EPA. (2002). Perchlorate Environmental Contamination: Toxicological Review and Risk Characterization, External Review Draft, NCEA-1-0503, Office of Research and Development, US EPA, Washington D.C.
55. Ward, K. W., Blumenthal, G. M., Welsch, F., and Pollack, G. M. (1997). Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice. Toxicol. Appl. Pharmacol. 145, 311-322.
56. Ward, R. C., Travis, C. C., Hetrick, D. M., Andersen, M. E., and Gargas, M. L. (1988). Pharmacokinetics of tetrachloroethylene. Toxicol. Appl. Pharmacol. 93, 108-117.
57. Weiss, B. (2000). Vulnerability of children and the developing brain to neurotoxic hazards. Environ. Health Perspect. 108(Suppl 3), 375-381.
58. Welsch, F., Blumenthal, G. M., and Conolly, R. B. (1995). Physiologically based pharmacokinetic models applicable to organogenesis: Extrapolation between species and potential use in prenatal toxicity risk assessments. Toxicol. Lett. 82-83, 539-547.
59. You, L., Gazi, E., Archibeque-Engle, S., Casanova, M., Conolly, R. B., and Heck, H. D. (1999). Transplacental and lactational transfer of p,ṕ-DDE in Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 157, 134-144.